Aidoc has received FDA Breakthrough Device status for its AI solution that flags multiple critical conditions in CT scans.
Key Details
- 1Aidoc's new AI product can detect a variety of urgent, life-threatening conditions from CT scans.
- 2The solution operates within a single workflow, streamlining triage for radiologists.
- 3This is believed to be the first FDA Breakthrough Device designation for an AI covering such a broad scope in one tool.
- 4The FDA Breakthrough Device Program is intended to speed market access for innovative medical technologies.
Why It Matters
Breakthrough Device status can accelerate regulatory review, paving the way for faster clinical adoption of comprehensive triage AI tools. This could improve patient outcomes by expediting the detection and management of critical conditions.
Source
Radiology Business
Related News
•Radiology Business
FDA Approves 56 New AI Radiology Devices, Total Tops 1,000
FDA updates its list with 56 new AI-powered radiology devices, bringing the total to over 1,000 approved tools.
•HealthExec
US Executive Order and HHS Strategy Set AI Policy Directions for Healthcare
The White House executive order and new HHS strategy shift US policy towards unified AI standards and expanded adoption in healthcare.
•Radiology Business
a2z Radiology Raises $5M, Lands FDA Clearance for Multi-Condition CT AI
Boston-based a2z Radiology raised $4.5M and earned FDA clearance for its Unified Triage AI solution for abdominal and pelvic CT scans.